Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

283 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Safety, Tolerability, and Pharmacokinetics of Same-Knee Intra-Articular Injection of Corticosteroid and Lorecivivint Within 7 Days: An Open-Label, Randomized, Parallel-Arm Study.
Fineman MS, McAlindon TE, Lattermann C, Swearingen CJ, Kennedy S, Lopez VA, Simsek I, Tambiah JRS, Yazici Y. Fineman MS, et al. Among authors: yazici y. Rheumatol Ther. 2023 Dec;10(6):1741-1752. doi: 10.1007/s40744-023-00604-7. Epub 2023 Oct 30. Rheumatol Ther. 2023. PMID: 37902943 Free PMC article.
Phase 3, 56-week, randomised, double-blind, placebo-controlled study utilising patient-reported and radiographic outcomes evaluating the efficacy and safety of a lorecivivint injection in patients with moderate to severe knee osteoarthritis: OA-11 Study.
Yazici Y, Tambiah JRS, Swearingen CJ, Britt J, Kennedy S, Fineman MS, Simsek I, Solomon E, McAlindon TE. Yazici Y, et al. Clin Exp Rheumatol. 2025 Jan 13. doi: 10.55563/clinexprheumatol/hjt118. Online ahead of print. Clin Exp Rheumatol. 2025. PMID: 39808286
A Phase 3, 28-week, multicentre, randomised, double-blind, placebo-controlled trial (OA-10) to evaluate the efficacy and safety of a single injection of lorecivivint in the target knee joint of moderately to severely symptomatic osteoarthritis patients.
Yazici Y, Tambiah JRS, Swearingen CJ, Lopez VA, Kennedy S, Fineman MS, Simsek I, Solomon E, Mcalindon TE. Yazici Y, et al. Clin Exp Rheumatol. 2025 Jan 13. doi: 10.55563/clinexprheumatol/gskbin. Online ahead of print. Clin Exp Rheumatol. 2025. PMID: 39808288
Women, men, and rheumatoid arthritis: analyses of disease activity, disease characteristics, and treatments in the QUEST-RA study.
Sokka T, Toloza S, Cutolo M, Kautiainen H, Makinen H, Gogus F, Skakic V, Badsha H, Peets T, Baranauskaite A, Géher P, Ujfalussy I, Skopouli FN, Mavrommati M, Alten R, Pohl C, Sibilia J, Stancati A, Salaffi F, Romanowski W, Zarowny-Wierzbinska D, Henrohn D, Bresnihan B, Minnock P, Knudsen LS, Jacobs JW, Calvo-Alen J, Lazovskis J, Pinheiro Gda R, Karateev D, Andersone D, Rexhepi S, Yazici Y, Pincus T; QUEST-RA Group. Sokka T, et al. Among authors: yazici y. Arthritis Res Ther. 2009;11(1):R7. doi: 10.1186/ar2591. Epub 2009 Jan 14. Arthritis Res Ther. 2009. PMID: 19144159 Free PMC article.
Work disability remains a major problem in rheumatoid arthritis in the 2000s: data from 32 countries in the QUEST-RA study.
Sokka T, Kautiainen H, Pincus T, Verstappen SM, Aggarwal A, Alten R, Andersone D, Badsha H, Baecklund E, Belmonte M, Craig-Müller J, da Mota LM, Dimic A, Fathi NA, Ferraccioli G, Fukuda W, Géher P, Gogus F, Hajjaj-Hassouni N, Hamoud H, Haugeberg G, Henrohn D, Horslev-Petersen K, Ionescu R, Karateew D, Kuuse R, Laurindo IM, Lazovskis J, Luukkainen R, Mofti A, Murphy E, Nakajima A, Oyoo O, Pandya SC, Pohl C, Predeteanu D, Rexhepi M, Rexhepi S, Sharma B, Shono E, Sibilia J, Sierakowski S, Skopouli FN, Stropuviene S, Toloza S, Valter I, Woolf A, Yamanaka H; QUEST-RA. Sokka T, et al. Arthritis Res Ther. 2010;12(2):R42. doi: 10.1186/ar2951. Epub 2010 Mar 12. Arthritis Res Ther. 2010. PMID: 20226018 Free PMC article.
Introduction, vasculitis 2025.
Yazici H, Yazici Y. Yazici H, et al. Among authors: yazici y. Curr Opin Rheumatol. 2025 Jan 1;37(1):1-2. doi: 10.1097/BOR.0000000000001069. Epub 2024 Nov 28. Curr Opin Rheumatol. 2025. PMID: 39600288 No abstract available.
283 results